Navigation Links
BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines
Date:12/7/2009

r the DHHS Request for Proposals for an Anthrax Recombinant Protective Antigen (rPA) Vaccine for the Strategic National Stockpile, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, and/or process validation of manufacturing processes for our product candidates, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC"). In particular, there can be no assurance that the Company will be awarded further government funding to support development of its second generation anthrax vaccine.

For more information about PharmAthene, please visit www.PharmAthene.com.

SOURCE PharmAthene, Inc.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vivakor Announces Additions to Board of Directors and Scientific Advisory Board
2. ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis
3. AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
4. BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement
5. Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)
6. Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters Over-Allotment Option
7. Gamida Cell Announces Feasibility Study With Weill Cornell Medical College
8. Simcere Announces 105 Drugs Included in Chinas National Drug Reimbursement List
9. Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia
10. PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT
11. Ohio Capital Fund Announces Sponsorship of Minority Business Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015 ... 22 september 2015 på  http://www.openinnovationinscience.at till ... in Science" som hålls i ... färsk undersökning med internationella forskare och vetenskapsmän ... är hälsovetenskapens två största utmaningar bristen på ...
(Date:7/2/2015)... NY (PRWEB) , ... July 03, 2015 , ... Cuvettes have been used in countless ... style catalog to find the cuvette they needed. As expected, this was a daunting ... order the wrong part because they were not able to navigate the complex catalog structure. ...
(Date:7/2/2015)... Calif. (PRWEB) , ... July 02, 2015 , ... Sleepless ... improve an individual’s quality of sleep, launched its Indiegogo campaign on June 23. Sound ... Luzi's voice command technology makes it effortless to use, while the integration of the ...
(Date:7/1/2015)... , July 1, 2015   Decision Resources ... cited advantages of Otezla are its oral administration, ... as reported by surveyed rheumatologists. Otezla was the ... the treatment of active psoriatic arthritis in ... standard of care includes conventional oral treatments including ...
Breaking Biology Technology:Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3New Cuvette E-Commerce Website Launched by FireflySci 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3
... , , ... , Transcriptor Reverse Transcriptase is a new recombinant,reverse transcriptase ... polymerase activity, unwinding,activity, and, importantly, RNase H activity. , ... , Due to the special recombinant structure of Transcriptor,Reverse ...
... , , , ... Protector RNase Inhibitor Is a new type of ... interfere with the performance of enzymes in an assay - even,when high amounts (e.g., ... RNA samples. , Is fully active over a wide pH range of ...
... , , , ... The FastStart Taq DNA Polymerase , ... FastStart Taq DNA Polymerase, a chemically modified version,of Taq DNA Polymerase for hot start PCR, was ... The most robust enzyme preparation,currently available , , ...
Cached Biology Technology:Increase the Power and Sensitivity for Your cDNA,Synthesis with the New Transcriptor Reverse Transcriptase 2Increase the Power and Sensitivity for Your cDNA,Synthesis with the New Transcriptor Reverse Transcriptase 3Increase the Power and Sensitivity for Your cDNA,Synthesis with the New Transcriptor Reverse Transcriptase 4Protector RNase Inhibitor Enhance the Protection of,RNA against Degradation 2Challenge the Performance of Your Hot-Start PCRs,with FastStart Taq DNA Polymerase and,the Novel FastStart High Fidelity PCR System 2
(Date:6/25/2015)... DALLAS , June 25, 2015 ... report "Fingerprint Sensors Market by Type (Swipe & Area), Technology, ... (Mobile, Government, Healthcare, Commercial Security & Others) & ... published by marketsandmarkets, the said market is expected ... CAGR of 17.1%. Browse 76 ...
(Date:6/24/2015)... 24, 2015 This report provides market analysis ... six years. It contains an analysis of the drivers, ... their impact from the short, medium, and long term ... industry, market, and technology trends that currently, prevail in ... concerned authorities to efficiently manage the increasing marine traffic ...
(Date:6/23/2015)... MINNETONKA, Minn. , June 23, 2015 /PRNewswire/ ... technology company that supports the entire spectrum of ... iMedNet ™ , the company,s ... has been awarded a Silver 2015 Stevie® Award ... the Health Products & Services Website category.  The ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... release is also available in Chinese on ... stem cell scientists have published new research that improves the ... by Dr Hsiao Chang Chan, from the Chinese University of ... Research into differentiation has led to a variety of breakthroughs ...
... that the drug, ivacaftor (VX-770), significantly improves lung function in ... phase III clinical trial study, "A CFTR Potentiator in Patients ... W. Ramsey, MD of Seattle Children,s Research Institute and the ... England Journal of Medicine . Ivacaftor, also known as ...
... Ill. The conventional wisdom that says the 20th ... more than a myth, according to a forthcoming study ... law., Law professor Paul Heald says overall varietal diversity ... apples in the U.S. actually has increased over the ...
Cached Biology News:Reprogramming stem cells to a more basic form results in more effective transplant, study shows 2Study shows new medication effectively treats underlying cause of cystic fibrosis 2Study: Crop diversity myths persist in media 2Study: Crop diversity myths persist in media 3
Application: for RNase- decontamination , Registered Trademark of Ambion. ,Special grade: for molecular biology Density: 1.00 g/mL (20 C) Suitab tst: RNase decontamination in accordance...
... Application: A cleaning agent for ... surfaces, countertops, and pipettors. ... eliminating RNase contamination from microcentrifuge ... reactions. ,RNase Zap (R) ...
Mol wt: average mol wt12,360.96 Da by calculation...
... a series of media originally developed at the ... for the large scale propagation of cells from ... used for the growth and maintenance of cell ... viruses in these cell lines. One of the ...
Biology Products: